2月24日，川恒股份涨5.06%，截至发稿，报40.48元/股，成交1.63亿元，换手率0.68%，总市值245.98亿 元。 资料显示，贵州川恒化工股份有限公司位于贵州省黔南布依族苗族自治州福泉市龙昌镇，成立日期2002 年11月25日，上市日期2017年8月25日，公司主营业务涉及磷酸及磷酸盐产品的生产、销售。主营业务 收入构成为：磷酸28.41%，饲料级磷酸二氢钙25.11%，磷酸一铵21.29%，磷酸铁9.46%，磷矿石 6.93%，其他产品3.56%，贸易收入1.94%，其他1.57%，铁精粉1.11%，硫酸铵0.61%。 从基金十大重仓股角度 数据显示，长安基金旗下1只基金重仓川恒股份。长安鑫禧混合A（005477）四季度持有股数18.5万股， 占基金净值比例为3.19%，位居第十大重仓股。根据测算，今日浮盈赚取约36.07万元。 长安鑫禧混合A（005477）成立日期2018年2月7日，最新规模5844.11万。今年以来收益4.87%，同类排 名3959/8994；近一年收益27.45%，同类排名3939/8199；成立以来亏损52.83%。 长安鑫禧混合A（005477）基金经理为江博文。 截 ...

Core Viewpoint - Chuanheng Co., Ltd. has shown significant stock price growth and strong financial performance, indicating potential investment opportunities in the chemical industry, particularly in phosphate products. Group 1: Stock Performance - As of January 19, Chuanheng's stock price increased by 2.02%, reaching 39.37 CNY per share, with a total market capitalization of 23.92 billion CNY [1] - Year-to-date, the stock price has risen by 7.39%, with a 5-day increase of 5.83%, a 20-day increase of 11.28%, and a 60-day increase of 36.28% [1] Group 2: Financial Performance - For the period from January to September 2025, Chuanheng achieved a revenue of 5.804 billion CNY, representing a year-on-year growth of 46.08%, and a net profit attributable to shareholders of 0.965 billion CNY, up by 43.50% [2] - Cumulative cash dividends since the company's A-share listing amount to 2.133 billion CNY, with 1.729 billion CNY distributed over the past three years [3] Group 3: Shareholder Structure - As of January 9, the number of shareholders for Chuanheng was 29,300, a decrease of 2.14% from the previous period, with an average of 20,364 circulating shares per shareholder, an increase of 2.19% [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited and Shenwan Hongyuan Securities Co., Ltd., with notable increases in their holdings [3]

Core Viewpoint - The financial performance of Chuanheng Co., Ltd. shows significant growth in revenue and net profit, indicating a strong operational capacity and market demand for its phosphate products [2]. Group 1: Financial Performance - For the period from January to September 2025, Chuanheng Co., Ltd. achieved a revenue of 5.804 billion yuan, representing a year-on-year increase of 46.08% [2]. - The net profit attributable to shareholders for the same period was 965 million yuan, reflecting a year-on-year growth of 43.50% [2]. - Cumulative cash dividends since the company's A-share listing amount to 2.133 billion yuan, with 1.729 billion yuan distributed over the past three years [3]. Group 2: Shareholder and Market Activity - As of January 9, 2025, the number of shareholders for Chuanheng Co., Ltd. was 29,300, a decrease of 2.14% from the previous period [2]. - The average number of circulating shares per shareholder increased by 2.19% to 20,364 shares [2]. - The financing balance for Chuanheng Co., Ltd. reached 476 million yuan, accounting for 2.06% of its market capitalization, which is above the 90th percentile of the past year [1]. Group 3: Business Operations - Chuanheng Co., Ltd. specializes in the production and sale of phosphate and phosphate-related products, with the main revenue sources being phosphoric acid (28.41%), feed-grade dicalcium phosphate (25.11%), and monoammonium phosphate (21.29%) [1]. - The company is located in the Qiannan Buyi and Miao Autonomous Prefecture of Guizhou Province and was established on November 25, 2002, with its shares listed on August 25, 2017 [1].

Core Viewpoint - Chuanheng Co., Ltd. has shown a mixed performance in stock price and financial results, with a notable increase in revenue and net profit year-on-year, while experiencing fluctuations in stock price and trading volume [1][2]. Group 1: Stock Performance - On January 16, Chuanheng's stock price decreased by 2.02%, trading at 38.29 CNY per share, with a total market capitalization of 23.268 billion CNY [1]. - Year-to-date, the stock price has increased by 4.45%, with a 0.75% decline over the last five trading days, a 9.00% increase over the last 20 days, and a 33.88% increase over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Chuanheng achieved a revenue of 5.804 billion CNY, representing a year-on-year growth of 46.08%, and a net profit attributable to shareholders of 0.965 billion CNY, up 43.50% year-on-year [2]. Group 3: Shareholder and Dividend Information - Since its A-share listing, Chuanheng has distributed a total of 2.133 billion CNY in dividends, with 1.729 billion CNY distributed over the last three years [3]. - As of September 30, 2025, the number of shareholders decreased to 29,300, with an average of 20,364 circulating shares per shareholder, an increase of 2.19% from the previous period [2][3].

Group 1 - The stock of Chuanheng Co., Ltd. fell by 1.33% on December 30, closing at 36.23 yuan per share, with a trading volume of 7.41 million yuan and a turnover rate of 0.03%, resulting in a total market capitalization of 22.016 billion yuan [1] - Chuanheng Co., Ltd. is located in the Qiannan Buyi and Miao Autonomous Prefecture of Guizhou Province, established on November 25, 2002, and listed on August 25, 2017. The company primarily engages in the production and sales of phosphoric acid and phosphate products [1] - The revenue composition of Chuanheng Co., Ltd. includes phosphoric acid (28.41%), feed-grade dicalcium phosphate (25.11%), monoammonium phosphate (21.29%), iron phosphate (9.46%), phosphate rock (6.93%), other products (3.56%), trading income (1.94%), others (1.57%), iron concentrate (1.11%), and ammonium sulfate (0.61%) [1] Group 2 - From the perspective of major fund holdings, one fund under Nord Fund has a significant position in Chuanheng Co., Ltd. The Nord Quantitative Core A (006267) held 50,500 shares in the third quarter, accounting for 1.11% of the fund's net value, ranking as the fifth-largest holding [2] - The Nord Quantitative Core A (006267) was established on November 22, 2018, with a latest scale of 93.2332 million yuan. Year-to-date returns are 39.64%, ranking 2049 out of 8087 in its category; the one-year return is 34.58%, ranking 2322 out of 8085; and since inception, the return is 53.24% [2] - The fund manager of Nord Quantitative Core A (006267) is Wang Hengnan, who has a cumulative tenure of 7 years and 41 days, with the current total asset scale of 245 million yuan. The best fund return during his tenure is 54.21%, while the worst is -35.81% [2]

Summary of Chuanheng Co., Ltd. Conference Call Company Overview - Chuanheng Co., Ltd. specializes in the production of phosphoric acid and other chemical products from phosphate rock using wet process technology. The company has increased its investment in technology research and development, with the proportion of technical personnel rising from 10% in 2020 to 20% in 2024 [2][5]. Industry Insights - The company is a leading player in the domestic phosphate chemical industry, with a significant shift in product structure. The revenue share of traditional pillar product feed-grade dicalcium phosphate has decreased from 67.67% in 2017 to 24.47% in 2024, while phosphoric acid products are expected to become the largest revenue source in 2024 [2][3]. Key Financial Metrics - The company’s design capacity for feed-grade dicalcium phosphate is 510,000 tons, making it one of the largest producers globally. The price has stabilized and begun to rise since 2023 due to the ban on antibiotics and the demand for large-scale farming [2][7]. - The company’s financial strategy has shifted to a more aggressive approach, with a current ratio of 1.17 and a quick ratio of 0.9, both at five-year lows. However, high-margin products like industrial-grade ammonium phosphate and feed-grade dicalcium phosphate are expected to support cash flow [4][10]. Revenue and Profitability Forecast - Projected revenues for 2025, 2026, and 2027 are expected to be CNY 7.457 billion, CNY 7.878 billion, and CNY 8.294 billion, with gross margins of approximately 34.4%, 36.2%, and 38.1% respectively [4][12]. - The company’s valuation using FCFF and relative valuation methods suggests a 2025 forecast PE ratio of 17-20, with a fair value range of CNY 22.3 billion to CNY 26.256 billion, translating to a share price of CNY 36.73 to CNY 43.21 [4][13]. Market Dynamics - China's phosphate rock reserves are limited, and environmental constraints lead to a tight supply. The demand for wet-process phosphoric acid in lithium battery materials has rapidly increased from 7% in 2021 to 17% in 2024 [2][9]. - The market for industrial-grade ammonium phosphate is benefiting from stringent national fire safety standards, while the fertilizer-grade ammonium phosphate market faces oversupply issues due to low-cost production by small enterprises [8][9]. Risks and Challenges - The company faces operational risks, including financial, technical, and market management risks, which could impact long-term development. Continuous monitoring and effective management strategies are necessary to mitigate these risks [14]. Conclusion - Chuanheng Co., Ltd. is positioned for growth in the phosphate chemical industry, supported by strong demand dynamics and a strategic focus on high-margin products. The company’s financial health, while under pressure from aggressive expansion, remains manageable due to its product mix and market positioning.

Investment Rating - The report assigns an "Outperform" rating to the company for the first time, with a fair value range of 36.73 to 43.21 CNY per share, indicating a 22% premium over the current stock price of 35.35 CNY [5][3]. Core Insights - The company is a leading player in the phosphate chemical industry in China, leveraging high-quality phosphate rock resources to establish a strong competitive advantage. It has a comprehensive industrial chain that integrates mining and processing [13][19]. - The company has a total designed production capacity of 510,000 tons per year for feed-grade dicalcium phosphate, making it the largest producer globally. The supply-demand balance in the industry is tightening, with product prices expected to stabilize and gradually increase from 2023 onwards [2][38]. - The company is also focusing on high-purity ammonium phosphate for fire safety applications, benefiting from stringent national fire safety standards and high added value [2][38]. - The demand for phosphate rock is expected to increase due to the growth of the energy storage sector, with significant increases in global battery shipments projected from 2025 to 2027 [2][38]. Financial Forecast and Valuation - The company is projected to achieve net profits of 1.313 billion CNY, 1.526 billion CNY, and 1.755 billion CNY for the years 2025, 2026, and 2027, respectively. The corresponding earnings per share are expected to be 2.16 CNY, 2.51 CNY, and 2.89 CNY [3][4]. - The report anticipates a steady increase in revenue, with total revenue expected to reach 7.45 billion CNY in 2025, reflecting a 26.1% year-on-year growth [4][3]. - The company's EBIT margin is projected to improve from 23.5% in 2025 to 27.5% in 2027, indicating enhanced profitability [4][3]. Industry Overview - The phosphate chemical industry in China is characterized by high resource barriers and strong supply constraints, with the company positioned to benefit from these dynamics [3][19]. - The company has developed a complete product system covering five major sectors, including basic raw materials, new energy materials, and traditional feed additives, which supports its strategic transition towards diversified markets [19][20]. - The company has been actively expanding its international market presence, with international sales increasing from 373 million CNY in 2017 to 1.845 billion CNY in 2024, reflecting its growing operational capabilities [22][20].

Group 1 - The core point of the news is that Chuanheng Co., Ltd. experienced a decline of 5.05% in its stock price, reaching 36.87 CNY per share, with a trading volume of 247 million CNY and a turnover rate of 1.11%, resulting in a total market capitalization of 22.405 billion CNY [1] - Chuanheng Co., Ltd. is based in Guizhou Province and was established on November 25, 2002. It was listed on August 25, 2017. The company's main business involves the production and sales of phosphoric acid and phosphate products [1] - The revenue composition of Chuanheng Co., Ltd. includes phosphoric acid (28.41%), feed-grade dicalcium phosphate (25.11%), monoammonium phosphate (21.29%), iron phosphate (9.46%), phosphate rock (6.93%), other products (3.56%), trading income (1.94%), others (1.57%), iron concentrate (1.11%), and ammonium sulfate (0.61%) [1] Group 2 - From the perspective of fund holdings, one fund under the Fuguo Fund has a significant position in Chuanheng Co., Ltd. The Fuguo CSI Value ETF (512040) held 790,100 shares in the third quarter, accounting for 1.38% of the fund's net value, making it the seventh-largest holding [2] - The Fuguo CSI Value ETF (512040) was established on November 7, 2018, with a current scale of 1.675 billion CNY. Year-to-date, it has achieved a return of 19.74%, ranking 2824 out of 4216 in its category. Over the past year, it has returned 19.03%, ranking 1938 out of 3937, and since inception, it has returned 162.93% [2]

Group 1 - The core point of the news is that Chuanheng Co., Ltd. experienced a decline of 5.05% in its stock price, reaching 36.87 CNY per share, with a trading volume of 248 million CNY and a turnover rate of 1.11%, resulting in a total market capitalization of 22.405 billion CNY [1] - Chuanheng Co., Ltd. is primarily engaged in the production and sales of phosphoric acid and phosphate products, with its main business revenue composition being: phosphoric acid 28.41%, feed-grade dicalcium phosphate 25.11%, monoammonium phosphate 21.29%, iron phosphate 9.46%, phosphate rock 6.93%, other products 3.56%, trading income 1.94%, others 1.57%, iron concentrate 1.11%, and ammonium sulfate 0.61% [1] Group 2 - According to data, a fund under Bank of China Securities holds a significant position in Chuanheng Co., Ltd., with the Bank of China Value Selection Mixed Fund (002601) holding 190,000 shares, accounting for 4.37% of the fund's net value, making it the third-largest holding [2] - The Bank of China Value Selection Mixed Fund (002601) has a total scale of 127 million CNY and has achieved a return of 36.7% this year, ranking 2121 out of 8147 in its category, with a one-year return of 23.76%, ranking 2731 out of 8056 [2]

Core Viewpoint - Chuanheng Co., Ltd. has shown significant stock price growth and strong financial performance in recent months, indicating a positive market sentiment and operational efficiency [1][2]. Financial Performance - For the period from January to September 2025, Chuanheng Co., Ltd. achieved a revenue of 5.804 billion yuan, representing a year-on-year increase of 46.08% [2]. - The net profit attributable to shareholders for the same period was 965 million yuan, reflecting a year-on-year growth of 43.50% [2]. Stock Performance - As of November 11, Chuanheng's stock price increased by 69.27% year-to-date, with a 16.19% rise over the last five trading days, 27.23% over the last 20 days, and 57.19% over the last 60 days [1]. - The stock was trading at 39.11 yuan per share, with a market capitalization of 23.766 billion yuan [1]. Shareholder Information - As of October 31, the number of shareholders increased to 32,700, up by 13.30% from the previous period [2]. - The average number of circulating shares per shareholder decreased by 11.74% to 18,249 shares [2]. Dividend Distribution - Chuanheng Co., Ltd. has distributed a total of 2.133 billion yuan in dividends since its A-share listing, with 1.729 billion yuan distributed over the past three years [3]. Major Shareholders - As of September 30, 2025, Hong Kong Central Clearing Limited was the fourth largest circulating shareholder, holding 11.3947 million shares, an increase of 7.0653 million shares from the previous period [3]. - Shenwan Hongyuan Securities Co., Ltd. ranked fifth among the top circulating shareholders, with a holding of 6.466 million shares, up by 429,600 shares [3].